血管紧张素原结构式
|
常用名 | 血管紧张素原 | 英文名 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
|---|---|---|---|---|
| CAS号 | 64315-16-8 | 分子量 | 1759.015 | |
| 密度 | 1.4±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C85H123N21O20 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
| 中文名 | 血管紧张素原 |
|---|---|
| 英文名 | Angiotensinogen |
| 英文别名 | 更多 |
| 密度 | 1.4±0.1 g/cm3 |
|---|---|
| 分子式 | C85H123N21O20 |
| 分子量 | 1759.015 |
| 精确质量 | 1757.925293 |
| LogP | 4.09 |
| 折射率 | 1.658 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
|
Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.
Am. J. Physiol. Renal Physiol. 310 , F372-84, (2016) Renovascular hypertension (RVH) is a common cause of both cardiovascular and renal morbidity and mortality. In renal artery stenosis (RAS), atrophy in the stenotic kidney is associated with an influx ... |
| Serine, α-aspartylarginylvalyltyrosylisoleucylhistidylprolylphenylalanylhistidylleucylleucylvalyltyrosyl- |
| α-Aspartylarginylvalyltyrosylisoleucylhistidylprolylphenylalanylhistidylleucylleucylvalyltyrosylserine |
| Angiotensinogen (1-14)(Porcine) |
| H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH |
查看所有供应商和价格请点击：